glp 1 drugs injection Understanding GLP-1 medications GLP-1 weight loss, side effects

The pathophysiology of DDES is complex, involving lacrimal gland mitochondrial dysfunction, neuro-inflammation, ocular surface dysbiosis, and meibomian gland dropout [122,123,124]

This approach recognizes that challenges with hunger, weight, and blood sugar are rarely caused by a single hormone in isolation

The oral segment is expected to grow rapidly with CAGR of 22.9% during the forecast period due to its convenience and noninvasive administration, which improves patient observation

doi: 10.1038/ijo.2011.158 [DOI] [PMC free article] [PubMed] [Google Scholar] 89

Retatrutide Pending Approval - A triple-action injectable drug targeting GLP-1, GIP, and glucagon receptors